Isabel Campos Pinto, PhD

Isabel Campos Pinto is a research scientist at the Bayer Satellite Laboratory at IBET, where she works in the development of next-generation sequencing (NGS) technologies for antibody discovery. Isabel holds a MSc in Biotechnology (Portugal), an industrial PhD in Health Sciences (UK) and a postdoctoral experience in Denmark, all in the field of antibody discovery. During her career Isabel has worked on the discovery and engineering of several antibodies, namely for COVID-19, Malaria and other neglected tropical diseases in a project funded by the Bill and Melinda Gates Foundation.